---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-079207"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2026-07-17T20:37:57+00:00"
generated_at: "2026-07-17T20:39:07.673211+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics enters into $2.085M convertible promissory note with SRX Global

## Summary
- Maximum loan amount $2,085,200; $750,000 funded May 23, $663,600 June 23, $671,600 July 14, 2026.
- Note bears 10% interest per annum, matures May 28, 2027.
- Convertible at lesser of $0.05 or 80% of avg of 5 lowest intraday prices in prior 20 days; 4.99% ownership cap.
- Company must file registration statement for resale of shares issuable upon conversion.
- Issuance exempt under Section 4(a)(2) and Rule 506(b); Lender is accredited investor.

## SEC filing metadata
- accession: 0001213900-26-079207
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2026-07-17T20:37:57+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390026079207/0001213900-26-079207-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026079207/ea0298463-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-079207
- JSON: https://secwatch.observer/filing/0001213900-26-079207.json
- Plain text: https://secwatch.observer/filing/0001213900-26-079207.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.